Cancer Therapy and Research Center at UTHSCSA

San Antonio, Texas 78229

0 studies enrolling now · 12 studies all time

What they study most

Advanced Malignancy, Breast Cancer, Breast Cancer Survivors, Cancer, Carcinoma, Squamous Cell of Head and Neck, Carcinoma, Squamous Cell of the Head and Neck, Head and Neck Cancer, Pain, Refractory or Relapsed Solid Tumors, Salivary Gland Malignancy, Small-Cell Lung Cancer, Squamous Cell Carcinoma

Studies at this site

• Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer — Completed
• Bevacizumab/Ph 2 for Locally Advanced Head and Neck Cancer — Completed
• Radiation and Cetuximab Plus Intratumoral EGFR Antisense DNA in Locally Advanced Head and Neck Squamous Cell Carcinoma — Completed
• Safety of RAD001 in Combination With Cisplatin and Etoposide in Lung Cancer Patients — Completed
• Impact of COX2 on Sera Biomarkers From Obese Subjects — Completed
• Postoperative Radiotherapy and Panitumumab in High-Risk Salivary Gland Malignancies — Withdrawn before enrolling
• Oral Hydroxychloroquine Plus Oral Sorafenib to Treat Patients With Refractory or Relapsed Solid Tumors — Completed
• Women's Mammography Study To Improve Comfort During Mammography — Stopped early
• Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers — Completed
• Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Head and Neck Carcinoma — Completed
• XL999 Administered Intravenously to a Subject With Advanced Malignancies — NO_LONGER_AVAILABLE
• Frailty Study of Older Adults Getting Chemotherapy and Radiation Therapy — Stopped early